Owens-Illinois, Inc. Aktie News

O-I Glass is rated a "Strong Buy" due to its ongoing transformation and significant upside potential, despite recent share price weakness. OI's Fit to Win program is driving substantial cost reductions, with management targeting $650 million in savings by 2027 and EBITDA growth to $1.45 billion. OI trades at very low multiples compared to peers, offering potential upside of 54.8% to 235.6%, eve...

PERRYSBURG, Ohio , Oct. 07, 2025 (GLOBE NEWSWIRE) -- O-I Glass, Inc. (NYSE: OI) has scheduled its third quarter 2025 conference call and webcast for Wednesday, November 5, 2025, at 8 a.m. EST. The Company's news release for the third quarter 2025 earnings will be issued after the market closes on Tuesday, November 4.

I rate O-I Glass a Strong Buy thanks to its turnaround potential, cost-saving initiatives, and positioning for industry recovery. OI's Fit To Win program targets $250M in annual cost savings for 2025, with $145M already achieved, and aims for $650M+ by 2027. OI expects $150M–$200M in free cash flow for 2025, a significant improvement that can lead to a better balance sheet and shareholder returns.

O-I Glass Q2 EPS Beats by 29%

O-I Glass, Inc. (NYSE:OI ) Q2 2025 Earnings Conference Call July 30, 2025 8:00 AM ET Company Participants Christopher David Manuel - Vice President of Investor Relations Gordon J. Hardie - CEO, President & Director John A.

PERRYSBURG, Ohio, July 29, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE

Perrysburg, Ohio, July 22, 2025 (GLOBE NEWSWIRE) -- With newly validated 2024 data, O-I Glass confirms it has achieved two of its most ambitious sustainability goals -- six years ahead of schedule. Originally set for 2030, the company's targets for renewable electricity and greenhouse gas emissions have already been met, underscoring O-I's momentum in sustainable glass manufacturing and its com...

O-I Glass remains a 'strong buy' due to its simple, essential business model and deeply discounted valuation despite recent share price gains. Short-term financials are mixed, but management's 'Fit to Win' program and multi-phase growth strategy promise significant EBITDA and cash flow expansion by 2027 and 2029. Shares are trading at lower multiples than peers, offering compelling value and th...